Who's getting vaccinated — and who's not?

A clinician preparing to administer an investigational COVID-19 vaccine in September 2020. Johnson & Johnson's long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot, not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.
Johnson & Johnson via AP file
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.